Inventiva (IVA) Revenue & Revenue Breakdown
Inventiva Revenue Highlights
Latest Revenue (Y)
$17.48M
Latest Revenue (Q)
$2.73M
Main Geography (Y)
JAPAN
Inventiva Revenue by Period
Inventiva Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $17.48M | 43.50% |
| 2022-12-31 | $12.18M | 190.39% |
| 2021-12-31 | $4.19M | 1027.42% |
| 2020-12-31 | $372.00K | -94.68% |
| 2019-12-31 | $7.00M | 118.89% |
| 2018-12-31 | $3.20M | -50.97% |
| 2017-12-31 | $6.52M | -30.96% |
| 2016-12-31 | $9.45M | 93.77% |
| 2015-12-31 | $4.87M | 48.49% |
| 2014-12-31 | $3.28M | 7.13% |
| 2013-12-31 | $3.06M | - |
Inventiva generated $17.48M in revenue during NA 2023, up 43.50% compared to the previous quarter, and up 546.67% compared to the same period a year ago.
Inventiva Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $2.73M | -83.47% |
| 2023-12-31 | $16.54M | 149.79% |
| 2023-06-30 | $6.62M | -57.06% |
| 2022-12-31 | $15.42M | 22917.91% |
| 2022-06-30 | $67.00K | -98.35% |
| 2021-12-31 | $4.05M | 6138.46% |
| 2021-06-30 | $65.00K | -12.16% |
| 2021-03-31 | $74.00K | -64.93% |
| 2020-12-31 | $211.00K | 185.14% |
| 2020-06-30 | $74.00K | -14.94% |
| 2020-03-31 | $87.00K | -98.46% |
| 2019-12-31 | $5.67M | 324.98% |
| 2019-06-30 | $1.33M | -23.81% |
| 2019-03-31 | $1.75M | -45.70% |
| 2018-12-31 | $3.22M | -22.49% |
| 2018-06-30 | $4.16M | 420.11% |
| 2018-03-31 | $799.25K | -83.01% |
| 2017-12-31 | $4.70M | -10.33% |
| 2017-06-30 | $5.25M | 221.83% |
| 2017-03-31 | $1.63M | -78.54% |
| 2016-12-31 | $7.60M | 12.78% |
| 2016-06-30 | $6.74M | 185.26% |
| 2016-03-31 | $2.36M | -52.73% |
| 2015-12-31 | $5.00M | 309.90% |
| 2015-09-30 | $1.22M | -66.75% |
| 2015-06-30 | $3.66M | 200.73% |
| 2015-03-31 | $1.22M | - |
| 2015-01-31 | $1.22M | 48.49% |
| 2014-09-30 | $820.73K | - |
| 2014-06-30 | $820.73K | - |
| 2014-03-31 | $820.73K | - |
| 2014-01-31 | $820.73K | 7.13% |
| 2013-09-30 | $766.13K | - |
| 2013-06-30 | $766.13K | - |
| 2013-03-31 | $766.13K | - |
| 2013-01-31 | $766.13K | - |
Inventiva generated $2.73M in revenue during Q2 2024, up -83.47% compared to the previous quarter, and up 67.42% compared to the same period a year ago.
Inventiva Revenue Breakdown
Inventiva Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 | Dec 22 |
|---|---|---|
| JAPAN | $12.75M | - |
| China | $4.61M | $12.05M |
| France | $118.00K | $125.00K |
Latest
Inventiva's latest annual revenue breakdown by geography, as of Dec 23: JAPAN (72.95%), China (26.38%), and France (0.68%).
Inventiva Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| IMCR | Immunocore | $249.43M | $75.40M |
| ACLX | Arcellx | $110.32M | $26.03M |
| IPHA | Innate Pharma | $51.90M | $16.56M |
| IVA | Inventiva | $17.48M | $2.73M |
| NAMS | NewAmsterdam Pharma | $14.09M | $2.13M |
| JANX | Janux Therapeutics | $8.08M | $8.90M |
| VRCA | Verrica Pharmaceuticals | $5.12M | $-1.86M |
| HCWB | HCW Biologics | $2.84M | $426.42K |
| INBX | Inhibrx Biosciences | $1.80M | - |
| ANEB | Anebulo Pharmaceuticals | - | - |
| CGEM | Cullinan Oncology | - | - |
| RZLT | Rezolute | - | - |
| CMPX | Compass Therapeutics | - | - |
| VTYX | Ventyx Biosciences | - | - |
| PCVX | Vaxcyte | - | - |
| EWTX | Edgewise Therapeutics | - | - |
| MLYS | Mineralys Therapeutics | - | - |
| GLUE | Monte Rosa Therapeutics | - | $4.70M |
| VIGL | Vigil Neuroscience | - | - |